View Older Stories
-
Chipotle founder out as CEO as investor patience expires
-
Billionaire investor Ackman loses bitter ADP proxy battle
-
Activist Ackman looks for board seats, better returns at payroll firm ADP
-
Hedge fund Paulson & Co discloses 6.3 percent stake in Valeant
-
Billionaire investor Paulson joins Valeant board, shares jump
-
Small is lucrative for Wachtell, corporate America's legal defense force
-
Drugmaker Perrigo says CEO Hendrickson plans to retire
-
Humbled by Valeant, Ackman goes back to basics
-
Herbalife CEO talks about obesity, vindication at Milken Conference
-
Exclusive: Billionaire investor Julian Robertson pulls plug on protege fund
-
Ackman apologizes for Valeant losses, calls bet a mistake
-
Energy drags on Wall St. as oil falls further; airlines slide
-
Wall Street drifts with eyes on Fed; Intel drops
-
Sessions asks 46 Obama-era U.S. attorneys to resign
-
Allergan to pay $15 million over failing to disclose merger talks
-
Japan's Takeda to buy U.S. cancer drug maker Ariad in $5.2 billion deal
-
Pushed by investor Ackman, Chipotle adds four new directors
-
Hedge funds slow to adjust champagne tastes to beer budgets
-
Valeant may seek to clean up its name by changing it: Ackman
-
Exclusive: Ackman's Pershing Square shakes up fees amid losses
-
Activist Starboard demands rapid changes at Perrigo
-
Ackman buys into Chipotle, to talk to management; shares jump
-
Ackman releases new Herbalife video; stock climbs
-
Streetinsider.com's Hot Lunchtime Reads 6/7: (BIIB) (YHOO) (VRX) (RGLS) (TSLA)
-
Activist investor heavyweights form new lobbying arm
-
Regulatory filings show which Valeant investors exited in first quarter
-
Key player in Pershing Square's Valeant bet leaving firm
-
Exclusive: Valeant calls in investment banks to weigh options - sources
-
Ackman to face investor grilling after record quarterly loss
-
U.S. regulator sues ValueAct over Halliburton-Baker Hughes disclosures
-
Senate's request for info from Ackman related to Valeant: source
-
S&P says it may cut Ackman hedge fund's rating
-
Ackman's Pershing Square Holdings down 18.6 percent so far in 2016: investor
-
Bearish views abound at elite hedge fund conference
-
U.S. hedge funds boast lower losses as markets tumble further
-
Ackman's Pershing Square ends 2015 with 20.5 pct drop
-
Big U.S. pharmacies square off on Daraprim supplies
-
Ackman tells investors that this year could be his firm's worst ever
-
Ackman plays big role in laying out Canadian Pacific rail deal
-
Ackman boosts stake in drugmaker Valeant
-
Hedge funds' favorite stocks lag broader market: Goldman data
-
Ackman's Pershing Square Holdings off 24.5 percent YTD
-
Norfolk Southern hostile to Canadian Pacific's $28.4 billion bid
-
Valeant, Ackman must face U.S. insider trading lawsuit
-
Citron turns spotlight on Mallinckrodt, shares plunge
-
Ackman says Valeant likely to pay down debt in the next 18 months
-
Valeant investors divided on fate of CEO Pearson
-
Big bets on Valeant hit some hedge funds hard in October
-
Ackman, in email, says supports Valeant CEO Pearson
-
Ackman backs Valeant CEO as shares tumble to 2-1/2 year lows

